hypertension – hippokratia.gr

The role of moxonidine, a second generation centrally acting antihypertensive agent as antihypertensive therapy in the obese

Posted on March 4, 2019July 26, 2022 by admin

LETTER

Hippokratia 2014, 18(2):189

Karlafti E, Hatzitolios A, Savopoulos Ch
1st Medical Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece

Bioimpedance spectroscopy method to determine hypervolemia in maintenance hemodialysis patients

Posted on February 28, 2019July 26, 2022 by admin

ORIGINAL ARTICLE

Hippokratia 2015, 19(4):324-331

Merhametsiz O, Oguz EG, Yayar O, Bektan B, Canbakan B, Ayli D
Department of Nephrology, Diskapi Yildirim Beyazit Training and Research Hospital, Department of Internal Medicine, Ankara Numune Training and Research Hospital, Ankara, Turkey

The management of hypertension in hemodialysis and CAPD patients

Posted on September 11, 2018August 23, 2022 by admin

Hippokratia 2007, 11(4):171-174

M. Malliara

Antihypertensive agents and renal transplantation

Posted on September 11, 2018August 23, 2022 by admin

Hippokratia 2007, 11(1):3-12

G Vergoulas